A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin (with or without bevacizumab) or pemetrexed and cisplatin (with or without bevacizumab) in patients with advanced non–small cell lung cancer

Jean‐Charles Soria, Alex A. Adjei, Rastilav Bahleda et al. · European Journal of Cancer · 2017

Cited by 42 works. doi:10.1016/j.ejca.2017.08.027 Open-access PDF

Authors

References